MEDI.OL Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally...

Stats
Today's Volume	9 675.00
Average Volume	7 779.00
Market Cap	3.71B
EPS	NOK0 ( 2023-10-26 )
Last Dividend	NOK4.50 ( 2023-04-25 )
Next Dividend	NOK0 ( N/A )
P/E	31.67
ATR14	NOK2.34 (1.15%)

Correlation (AI algo v.1.1b): Overvalued: -3.56% NOK197.70 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Medistim ASA Correlation

10 Most Positive Correlations
XXL.OL	0.837
NAVA.OL	0.81
TOM.OL	0.804

10 Most Negative Correlations
ODL.OL	-0.897
SBX.OL	-0.82
FRO.OL	-0.804

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Medistim ASA Financials

Annual	2022
Revenue:	NOK486.26M
Gross Profit:	NOK379.78M (78.10 %)
EPS:	NOK6.25

Q3	2023
Revenue:	NOK124.10M
Gross Profit:	NOK101.75M (81.99 %)
EPS:	NOK1.430

Q2	2023
Revenue:	NOK137.39M
Gross Profit:	NOK107.49M (78.24 %)
EPS:	NOK1.800

Q1	2023
Revenue:	NOK129.26M
Gross Profit:	NOK103.36M (79.96 %)
EPS:	NOK1.410

Medistim ASA Dividends

(Q3/21)	(Q4/21)	(Q1/22)	(Q2/22)	(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)
NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK3.75 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK4.50 (N/A)	NOK0 (N/A)	NOK0 (N/A)

Medistim ASA Dividend Information - Dividend Junior

Dividend Sustainability Score: 0 - low (0.00%) | Divividend Growth Potential Score: 1.841 - No dividend expected

Information

First Dividend	NOK0.280	2005-04-29
Last Dividend	NOK4.50	2023-04-25
Next Dividend	NOK0	N/A
Payout Date	0000-00-00
Next Payout Date
# dividends	19	--
Total Paid Out	NOK28.30	--
Avg. Dividend % Per Year	1.55%	--
Score	1.59	--
Div. Sustainability Score	0
Div.Growth Potential Score	1.841
Div. Directional Score	0.921	--

Next Divdend (Est)
(2024-04-02)

NOK4.94 Estimate 7.92 %

Dividend Stability

0.32 Poor

Dividend Score

1.59

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2005	NOK0.280	2.98%
2006	NOK0.270	2.05%
2007	NOK0.400	2.42%
2008	NOK0.500	2.63%
2009	NOK0.600	3.90%
2010	NOK0.150	0.64%
2011	NOK0.150	0.60%
2012	NOK1.000	4.35%
2013	NOK1.100	5.50%
2014	NOK0.800	3.48%
2015	NOK1.400	4.67%
2016	NOK1.650	3.06%
2017	NOK1.750	2.27%
2018	NOK2.00	2.78%
2019	NOK2.25	3.37%
2020	NOK2.75	1.42%
2021	NOK3.00	1.20%
2022	NOK3.75	0.96%
2023	NOK4.50	1.93%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
AMSC.OL	Dividend Royal	2023-11-28	Quarterly	10	30.03%	7.40
VAR.OL	Dividend Royal	2023-11-03	Quarterly	2	12.77%	7.07
ALNG.OL	Dividend King	2023-11-27	Quarterly	1	19.80%	7.04
OKEA.OL	Dividend King	2023-12-01	Quarterly	2	9.47%	6.86
SOR.OL	Dividend King	2023-03-31	Annually	16	7.44%	6.65
DNB.OL	Dividend King	2023-04-26	Annually	20	6.66%	6.36
MELG.OL	Dividend King	2023-03-17	Annually	24	5.54%	5.95
AKRBP.OL	Dividend King	2023-11-01	Quarterly	8	6.47%	5.89
SVEG.OL	Dividend King	2023-10-26	Annually	24	6.14%	5.63
TOTG.OL	Dividend King	2023-03-31	Annually	16	4.96%	5.62

Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.